Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
40
REYN Quote, Financials, Valuation and Earnings
Last price:
$27.62
Seasonality move
:
-1.98%
Day range:
$27.43 - $27.85
52-week range:
$26.50 - $32.65
Dividend yield:
3.33%
P/E ratio:
15.78x
P/S ratio:
1.58x
P/B ratio:
2.81x
Volume:
951.7K
Avg. volume:
578K
1-year change:
4.27%
Market cap:
$5.8B
Revenue:
$3.8B
EPS (TTM):
$1.75
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | $3.3B | $3.6B | $3.8B | $3.8B | |
| Revenue Growth (YoY) | -3.5% | 7.62% | 8.98% | 7.34% | -1.6% | |
| Cost of Revenues | $2.2B | $2.3B | $2.7B | $3B | $2.8B | |
| Gross Profit | $880M | $973M | $811M | $776M | $942M | |
| Gross Profit Margin | 29.02% | 29.82% | 22.81% | 20.33% | 25.08% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $315M | $358M | $320M | $340M | $430M | |
| Other Inc / (Exp) | -$31M | -$31M | -$13M | -$22M | -- | |
| Operating Expenses | $339M | $356M | $320M | $340M | $430M | |
| Operating Income | $541M | $617M | $491M | $436M | $512M | |
| Net Interest Expenses | $209M | $70M | $48M | $76M | $119M | |
| EBT. Incl. Unusual Items | $301M | $516M | $430M | $338M | $393M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $76M | $153M | $106M | $80M | $95M | |
| Net Income to Company | $225M | $363M | $324M | $258M | $298M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $225M | $363M | $324M | $258M | $298M | |
| Basic EPS (Cont. Ops) | $1.11 | $1.78 | $1.54 | $1.23 | $1.42 | |
| Diluted EPS (Cont. Ops) | $1.11 | $1.77 | $1.54 | $1.23 | $1.42 | |
| Weighted Average Basic Share | $202.6M | $204.5M | $209.8M | $209.8M | $210M | |
| Weighted Average Diluted Share | $202.6M | $204.5M | $209.8M | $209.9M | $210M | |
| EBITDA | $633M | $681M | $583M | $533M | $661M | |
| EBIT | $542M | $582M | $474M | $416M | $537M | |
| Revenue (Reported) | $3B | $3.3B | $3.6B | $3.8B | $3.8B | |
| Operating Income (Reported) | $541M | $617M | $491M | $436M | $512M | |
| Operating Income (Adjusted) | $542M | $582M | $474M | $416M | $537M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $823M | $905M | $967M | $935M | $910M | |
| Revenue Growth (YoY) | 11.07% | 9.96% | 6.85% | -3.31% | -2.67% | |
| Cost of Revenues | $558M | $723M | $789M | $686M | $671M | |
| Gross Profit | $265M | $182M | $178M | $249M | $239M | |
| Gross Profit Margin | 32.2% | 20.11% | 18.41% | 26.63% | 26.26% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $97M | $77M | $90M | $115M | $101M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $102M | $82M | $95M | $115M | $101M | |
| Operating Income | $163M | $100M | $83M | $134M | $138M | |
| Net Interest Expenses | $13M | $12M | $20M | $31M | $25M | |
| EBT. Incl. Unusual Items | $150M | $88M | $63M | $103M | $113M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $37M | $22M | $15M | $25M | $27M | |
| Net Income to Company | $113M | $66M | $48M | $78M | $86M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $113M | $66M | $48M | $78M | $86M | |
| Basic EPS (Cont. Ops) | $0.54 | $0.31 | $0.23 | $0.37 | $0.41 | |
| Diluted EPS (Cont. Ops) | $0.54 | $0.31 | $0.23 | $0.37 | $0.41 | |
| Weighted Average Basic Share | $209.7M | $209.7M | $209.9M | $210M | $210.1M | |
| Weighted Average Diluted Share | $209.8M | $209.8M | $209.9M | $210M | $210.3M | |
| EBITDA | $187M | $128M | $113M | $165M | $171M | |
| EBIT | $163M | $100M | $83M | $134M | $138M | |
| Revenue (Reported) | $823M | $905M | $967M | $935M | $910M | |
| Operating Income (Reported) | $163M | $100M | $83M | $134M | $138M | |
| Operating Income (Adjusted) | $163M | $100M | $83M | $134M | $138M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.4B | $3.8B | $3.8B | $3.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.2B | $2.6B | $3B | $3B | $2.7B | |
| Gross Profit | $969M | $849M | $759M | $878M | $1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $344M | $342M | $340M | $403M | $431M | |
| Other Inc / (Exp) | -$32M | -- | -- | -- | -- | |
| Operating Expenses | $360M | $324M | $347M | $385M | $431M | |
| Operating Income | $609M | $525M | $412M | $493M | $574M | |
| Net Interest Expenses | $92M | $49M | $60M | $119M | $103M | |
| EBT. Incl. Unusual Items | $485M | $445M | $339M | $352M | $471M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $144M | $113M | $83M | $85M | $102M | |
| Net Income to Company | $341M | $332M | $256M | $267M | $368M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $341M | $332M | $256M | $267M | $369M | |
| Basic EPS (Cont. Ops) | $1.65 | $1.57 | $1.23 | $1.28 | $1.75 | |
| Diluted EPS (Cont. Ops) | $1.65 | $1.57 | $1.23 | $1.28 | $1.75 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $709M | $598M | $510M | $595M | $727M | |
| EBIT | $609M | $490M | $395M | $473M | $599M | |
| Revenue (Reported) | $3.2B | $3.4B | $3.8B | $3.8B | $3.7B | |
| Operating Income (Reported) | $609M | $525M | $412M | $493M | $574M | |
| Operating Income (Adjusted) | $609M | $490M | $395M | $473M | $599M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.5B | $2.7B | $2.7B | $2.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.7B | $2B | $2.2B | $2.1B | $2B | |
| Gross Profit | $706M | $582M | $530M | $632M | $696M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $260M | $244M | $264M | $327M | $328M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $286M | $254M | $281M | $326M | $328M | |
| Operating Income | $420M | $328M | $249M | $306M | $368M | |
| Net Interest Expenses | $57M | $36M | $48M | $91M | $75M | |
| EBT. Incl. Unusual Items | $363M | $292M | $201M | $215M | $293M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $112M | $72M | $49M | $54M | $61M | |
| Net Income to Company | $251M | $220M | $152M | $161M | $231M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $251M | $220M | $152M | $161M | $232M | |
| Basic EPS (Cont. Ops) | $1.21 | $1.04 | $0.73 | $0.77 | $1.10 | |
| Diluted EPS (Cont. Ops) | $1.21 | $1.04 | $0.73 | $0.77 | $1.10 | |
| Weighted Average Basic Share | $608.2M | $629.2M | $629.6M | $629.9M | $630.3M | |
| Weighted Average Diluted Share | $608.6M | $629.5M | $629.6M | $629.9M | $630.6M | |
| EBITDA | $492M | $409M | $336M | $398M | $464M | |
| EBIT | $420M | $328M | $249M | $306M | $368M | |
| Revenue (Reported) | $2.4B | $2.5B | $2.7B | $2.7B | $2.7B | |
| Operating Income (Reported) | $420M | $328M | $249M | $306M | $368M | |
| Operating Income (Adjusted) | $420M | $328M | $249M | $306M | $368M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $102M | $312M | $164M | $38M | $115M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $13M | $292M | $316M | $348M | $347M | |
| Inventory | $418M | $419M | $583M | $722M | $524M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $16M | $13M | $19M | $41M | $41M | |
| Total Current Assets | $570M | $1.1B | $1.1B | $1.2B | $1B | |
| Property Plant And Equipment | $579M | $673M | $732M | $787M | $788M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.9B | $1.9B | $1.9B | $1.9B | $1.9B | |
| Other Intangibles | $1.1B | $1.1B | $1.1B | $1B | $1B | |
| Other Long-Term Assets | $9M | $25M | $36M | $61M | $55M | |
| Total Assets | $4.2B | $4.7B | $4.8B | $4.9B | $4.8B | |
| Accounts Payable | $135M | $185M | $261M | $252M | $219M | |
| Accrued Expenses | $104M | $98M | $74M | $73M | $116M | |
| Current Portion Of Long-Term Debt | $21M | $25M | $25M | $25M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $11M | $14M | $16M | |
| Other Current Liabilities | $46M | $83M | $74M | $72M | $71M | |
| Total Current Liabilities | $378M | $432M | $484M | $496M | $478M | |
| Long-Term Debt | $4.2B | $2.2B | $2.1B | $2.1B | $1.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5B | $3.1B | $3.1B | $3.1B | $2.8B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $5M | $1M | $10M | $52M | $50M | |
| Common Equity | -$818M | $1.6B | $1.8B | $1.9B | $2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$818M | $1.6B | $1.8B | $1.9B | $2B | |
| Total Liabilities and Equity | $4.2B | $4.7B | $4.8B | $4.9B | $4.8B | |
| Cash and Short Terms | $102M | $312M | $164M | $38M | $115M | |
| Total Debt | $4.2B | $2.2B | $2.1B | $2.1B | $1.8B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $351M | $70M | $33M | $124M | $96M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $288M | $319M | $289M | $345M | $339M | |
| Inventory | $401M | $615M | $796M | $576M | $624M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $22M | $21M | $41M | $48M | $37M | |
| Total Current Assets | $1.1B | $1B | $1.2B | $1.1B | $1.1B | |
| Property Plant And Equipment | $642M | $711M | $756M | $776M | $808M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.9B | $1.9B | $1.9B | $1.9B | $1.9B | |
| Other Intangibles | $1.1B | $1.1B | $1B | $1B | $980M | |
| Other Long-Term Assets | $24M | $33M | $58M | $68M | $55M | |
| Total Assets | $4.7B | $4.7B | $4.9B | $4.8B | $4.8B | |
| Accounts Payable | $169M | $252M | $295M | $237M | $335M | |
| Accrued Expenses | $161M | $156M | $184M | $183M | $160M | |
| Current Portion Of Long-Term Debt | $25M | $25M | $25M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $16M | $19M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $401M | $468M | $548M | $467M | $543M | |
| Long-Term Debt | $2.3B | $2.1B | $2.1B | $2B | $1.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.2B | $3B | $3.1B | $2.9B | $2.8B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $3M | $3M | $42M | $52M | $34M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.6B | $1.7B | $1.8B | $1.9B | $2.1B | |
| Total Liabilities and Equity | $4.7B | $4.7B | $4.9B | $4.8B | $4.8B | |
| Cash and Short Terms | $351M | $70M | $33M | $124M | $96M | |
| Total Debt | $2.3B | $2.1B | $2.1B | $2B | $1.7B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $225M | $363M | $324M | $258M | $298M | |
| Depreciation & Amoritzation | $91M | $99M | $109M | $117M | $124M | |
| Stock-Based Compensation | -- | $5M | $4M | $5M | $14M | |
| Change in Accounts Receivable | -$19M | -$276M | -$29M | -$31M | $7M | |
| Change in Inventories | $2M | -- | -$165M | -$139M | $198M | |
| Cash From Operations | $403M | $319M | $310M | $219M | $644M | |
| Capital Expenditures | $109M | $143M | $141M | $128M | $104M | |
| Cash Acquisitions | -- | -- | -- | -- | -$6M | |
| Cash From Investing | -$128M | -$143M | -$141M | -$128M | -$110M | |
| Dividends Paid (Ex Special Dividend) | -- | -$124M | -$192M | -$192M | -$192M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $3.6B | -- | -- | -- | |
| Long-Term Debt Repaid | -$21M | -$1.4B | -$125M | -$25M | -$262M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$175M | -$3.5B | -- | -- | -$3M | |
| Cash From Financing | -$196M | $34M | -$317M | -$217M | -$457M | |
| Beginning Cash (CF) | $23M | $102M | $312M | $164M | $38M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $79M | $210M | -$148M | -$126M | $77M | |
| Ending Cash (CF) | $102M | $312M | $164M | $38M | $115M | |
| Levered Free Cash Flow | $294M | $176M | $169M | $91M | $540M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $113M | $66M | $48M | $78M | $86M | |
| Depreciation & Amoritzation | $24M | $28M | $30M | $31M | $33M | |
| Stock-Based Compensation | $1M | $2M | -- | $4M | $5M | |
| Change in Accounts Receivable | -$5M | $11M | -$37M | $39M | $34M | |
| Change in Inventories | -$16M | -$34M | -$62M | $38M | -$40M | |
| Cash From Operations | $144M | $104M | $17M | $216M | $124M | |
| Capital Expenditures | $33M | $28M | $30M | $26M | $31M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$33M | -$28M | -$30M | -$26M | -$31M | |
| Dividends Paid (Ex Special Dividend) | -$46M | -$48M | -$48M | -$48M | -$48M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$106M | -$7M | -$7M | -$101M | -$50M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$152M | -$55M | -$55M | -$149M | -$98M | |
| Beginning Cash (CF) | $392M | $49M | $101M | $83M | $101M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$41M | $21M | -$68M | $41M | -$5M | |
| Ending Cash (CF) | $351M | $70M | $33M | $124M | $96M | |
| Levered Free Cash Flow | $111M | $76M | -$13M | $190M | $93M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $341M | $332M | $256M | $267M | $368M | |
| Depreciation & Amoritzation | $100M | $108M | $115M | $122M | $128M | |
| Stock-Based Compensation | $4M | $6M | $3M | $11M | $18M | |
| Change in Accounts Receivable | -$244M | -$30M | $24M | -$46M | $8M | |
| Change in Inventories | $75M | -$214M | -$181M | $220M | -$48M | |
| Cash From Operations | $404M | $294M | $306M | $524M | $528M | |
| Capital Expenditures | $120M | $159M | $126M | $119M | $106M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$120M | -$159M | -$126M | -$119M | -$112M | |
| Dividends Paid (Ex Special Dividend) | -$77M | -$191M | -$192M | -$192M | -$192M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.6B | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.3B | -$225M | -$25M | -$119M | -$249M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3.6B | -- | -- | -- | -$3M | |
| Cash From Financing | $52M | -$416M | -$217M | -$314M | -$444M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $336M | -$281M | -$37M | $91M | -$28M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $284M | $135M | $180M | $405M | $422M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $251M | $220M | $152M | $161M | $231M | |
| Depreciation & Amoritzation | $72M | $81M | $87M | $92M | $96M | |
| Stock-Based Compensation | $4M | $5M | $4M | $10M | $14M | |
| Change in Accounts Receivable | -$272M | -$26M | $27M | $12M | $13M | |
| Change in Inventories | $17M | -$197M | -$213M | $146M | -$100M | |
| Cash From Operations | $147M | $122M | $118M | $423M | $307M | |
| Capital Expenditures | $85M | $101M | $86M | $77M | $79M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$85M | -$101M | -$86M | -$77M | -$79M | |
| Dividends Paid (Ex Special Dividend) | -$77M | -$144M | -$144M | -$144M | -$144M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $3.6B | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.3B | -$119M | -$19M | -$113M | -$100M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3.5B | -- | -- | -$3M | -$3M | |
| Cash From Financing | $187M | -$263M | -$163M | -$260M | -$247M | |
| Beginning Cash (CF) | $694M | $505M | $366M | $171M | $351M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $249M | -$242M | -$131M | $86M | -$19M | |
| Ending Cash (CF) | $943M | $263M | $235M | $257M | $332M | |
| Levered Free Cash Flow | $62M | $21M | $32M | $346M | $228M | |
Get REYN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
REYN
Sector
P/E ratio
15.78x
17.73x
PEG ratio
0.43x
0.35x
P/B ratio
2.81x
1.67x
Price / LTM sales
1.58x
0.69x
Growth Metrics
REYN
Sector
Revenue growth
-2.67%
0.27%
Earnings growth
10.81%
-3.16%
Revenue (5-year growth)
3.63%
4.3%
Earnings forecast
$0.42
$0.31
Profitability
REYN
Sector
Profitability FY 2023
$942M
$575.2M
Return on invested capital
9.64%
5.51%
Return on assets
7.63%
3.55%
Return on equity
18.51%
8.37%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
7
Estimated Next Earnings Date
Jan
29
Balance Sheet
REYN
Sector
Total cash
$96M
$163.2M
Short term investments
--
$53.7M
Total assets
$4.8B
$1.9B
Long term debt
$1.7B
$145.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
